大成生化科技(00809.HK)完成配售12.29億股公司股份
格隆匯4月29日丨大成生化科技(00809.HK)公佈,有關擬增發12.29億股事宜,由於認購協議所載的所有先決條件已獲達成或豁免(視情況而定),根據認購協議的條款及條件,認購完成已於2020年4月29日落實。
認購方已按每股0.1080港元的認購價獲配發及發行合共12.29億股,相當於經擴大後已發行股本約13.8%。而緊隨認購完成後,認購方於公司經擴大已發行股本中擁有約28.2%的權益。
由於認購完成,根據可換股債券的條款及條件,發行在外可換股債券的轉換價已進一步由每股股份0.22港元調整至0.21港元,自2020年4月29日起生效,而公司於悉數轉換可換股債券後可發行的最高股份數目已根據經調整轉換價增加至5,172,759,833股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.